Announcements Trials
Browse Landscape

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 2Other hematologic neoplasm 2Myeloid 2Genitourinary 2Gastrointestinal 2Breast 2Sarcoma 1Plasma cell 1Other neoplasm 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Neoplasms 3Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 65pembrolizumab 56Gemcitabine 54Paclitaxel 51Blood Specimen Collection 45Carboplatin 44Bevacizumab 41Docetaxel 38Cisplatin 33Nivolumab 32Fluorouracil 31Capecitabine 28Radiotherapy 25Pemetrexed 25Irinotecan 25Standard of Care 24Interviews as Topic 24Magnetic Resonance Spectroscopy 23Leucovorin 22Erlotinib Hydrochloride 22atezolizumab 21Cetuximab 21Afatinib 21Oxaliplatin 19trametinib 18Exercise 18Ipilimumab 17Sorafenib 16Cyclophosphamide 16olaparib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Watchful Waiting × Tumor-Agnostic × Clear all
NCT05574738 2024-02-08

A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer

Cancer Research UK, Glasgow

Unknown
1,000 enrolled
Tumor-Agnostic

Neoplasms

NCT02978846 2018-10-05

Perceptions of Side Effects of Cancer Chemoradiotherapy

University of Southern California

Completed
62 enrolled
Tumor-Agnostic

Neoplasms

NCT03561467 2018-06-19

PARCOURS

University Hospital, Caen

Unknown
60 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡